Exact Sciences has launched a new genetic test that uses a blood or saliva sample to predict the risk of developing various cancers.
The Madison-based diagnostics company yesterday rolled out the Riskguard hereditary cancer test, which will be available for order starting March 12. It can provide insights on familial risk and specific genetic changes for 10 common cancers: colorectal, breast,...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
